{
    "Trade/Device Name(s)": [
        "TD-4239 Blood Glucose Monitoring System",
        "TD-4239 Multi Blood Glucose Monitoring System"
    ],
    "Submitter Information": "TaiDoc Technology Corporation",
    "510(k) Number": "K101635",
    "Predicate Device Reference 510(k) Number(s)": [
        "K094005"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR"
    ],
    "Summary Letter Date": "August 25, 2011",
    "Summary Letter Received Date": "August 29, 2011",
    "Submission Date": "June 7, 2010",
    "Regulation Number(s)": [
        "21CFR862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood",
        "Venous whole blood",
        "Neonatal whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "TD-4239 Blood Glucose Meter",
        "TD-4239 Multi Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor",
        "FAD-dependent glucose dehydrogenase (FAD-GDH)"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for TD-4239 Blood Glucose Monitoring System and TD-4239 Multi Blood Glucose Monitoring System for quantitative measurement of glucose in whole blood samples",
    "Indications for Use Summary": "TD-4239 Blood Glucose Monitoring System: For self-testing of glucose in fresh capillary whole blood from the finger by people with diabetes at home; TD-4239 Multi Blood Glucose Monitoring System: For professional, multiple-patient use in healthcare settings to measure glucose in capillary, venous, and neonatal whole blood samples",
    "fda_folder": "Clinical Chemistry"
}